KINIKSA PHARMACEUTICALS news, videos and press releases
For more news please use our advanced search feature.
KINIKSA PHARMACEUTICALS - More news...
KINIKSA PHARMACEUTICALS - More news...
- Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate Strategy
- Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
- Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance
- Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
- Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference
- Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference
- Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
- Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024
- NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
- Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
- Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024
- Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease
- Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis
- Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative
- Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
- Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
- Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
- Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart
- Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
- Kiniksa Pharmaceuticals Provides Corporate Update
- Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023
- Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution
- Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023
